Oct 27, 2018
Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol
Oct 25, 2018
BioArctic Announces Additional BAN2401 Phase 2b Study Results in Early Alzheimer's Disease Presented by Eisai at the 2018 CTAD Conference
Sep 20, 2018
19th Annual Conference on Alzheimer's Drug Discovery Highlights Multiple Approaches to Prevent and Treat Alzheimer's Disease
Sep 14, 2018
Life Molecular Imaging and SOFIE Announce PI-2620 Tau PET Tracer Production in the SOFIE Radiopharmacy Network
Sep 13, 2018
BioArctic SIgns a Research Agreement With Brain Biomarker Solutions in Gothenburg AB to Develop New Diagnostics for Alzheimer's Disease
Aug 29, 2018
KinoPharma and National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer's Disease
Aug 21, 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Aug 14, 2018
ProMIS Neurosciences Announces Second Quarter 2018 Results
Jul 31, 2018
ProMIS Neurosciences Issues White Paper Entitled 'State of the Art at AAIC 2018'
Jul 25, 2018
BioArctic Announces Detailed Results of the BAN2401 Phase 2b Study in Early Alzheimer's Disease Presented at AAIC 2018
Jul 25, 2018
Eisai And Biogen Announce Detailed Results Of Phase II Clinical Study Of BAN2401 In Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018
Jul 20, 2018
Highlights from Lilly's Alzheimer's Disease Pipeline at the Alzheimer's Association International Conference® 2018 (AAIC® 2018)
Jul 18, 2018
Eisai To Present Latest Data On Alzheimer's Disease / Dementia Pipeline At Alzheimer's Association International Conference 2018
Jul 10, 2018
ProMIS Neurosciences to Present Preclinical Data on Alzheimer's Disease Therapeutic Antibody PMN310 at Alzheimer's Association International Conference
Jul 05, 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Jul 05, 2018
Eisai And Biogen Announce Positive Topline Results Of The Final Analysis For BAN2401 At 18 Months
Apr 25, 2018
NYU Winthrop's Research Institute: Stem Cells Reengineered to Act Like Brain Neurons May Hold New Hope for Finding Treatments for Alzheimer's
Mar 27, 2018
Piramal Imaging Announces Strategic Partnership with PositronPharma for Manufacturing and Distribution of Neuraceq(TM) in Chile
Mar 14, 2018
ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results
Mar 07, 2018
EIP Pharma Publishes Positive Alzheimer's Disease Clinical Study Data with Neflamapimod